HemaCare Co. (OTCMKTS:HEMA – Get Free Report)’s share price was up 0.6% during mid-day trading on Thursday . The company traded as high as $25.31 and last traded at $25.31. Approximately 5,400 shares were traded during mid-day trading, a decline of 86% from the average daily volume of 39,950 shares. The stock had previously closed at $25.16.
HemaCare Price Performance
The stock’s 50-day moving average price is $25.31 and its 200-day moving average price is $25.31.
HemaCare Company Profile
HemaCare Corporation provides human-derived primary blood cells and tissues for biomedical research, and supporting cell therapy clinical trials and commercialization with apheresis collections in the United States. The company specializes in the customized collection, isolation, and testing of primary human blood cells and other biological products for research protocols and cellular therapy.
Featured Stories
- Five stocks we like better than HemaCare
- Stock Market Upgrades: What Are They?
- Hasbro’s Management Made All the Right Calls This Quarter
- Following Congress Stock Trades
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- Stock Splits, Do They Really Impact Investors?
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for HemaCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HemaCare and related companies with MarketBeat.com's FREE daily email newsletter.
